NONA KHUTSISHVILI: Open Payments
NPI 1457851966 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 36 payments from 12 companies in 2025. Trend: 2023 $845 · 2024 $975 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $218 |
| PFIZER INC. | 1 | $119 |
| GENZYME CORPORATION | 3 | $98 |
| Novartis Pharmaceuticals Corporation | 5 | $82 |
| Janssen Biotech, Inc. | 2 | $72 |
| UCB, Inc. | 4 | $69 |
| ABBVIE INC. | 4 | $66 |
| Lilly USA, LLC | 3 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Biofrontera Inc. | 2 | $41 |
Products named: ILUMYA, DUPIXENT, LITFULO, COSENTYX, TREMFYA, Bimzelx, SKYRIZI, TALTZ.
Industry payments across MD — which companies pay providers there.
